Japan Central Nervous System Therapeutic Market Size, Share, and COVID-19 Impact Analysis, By Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Disease, CNS Cancer, and Others), By Drug Class (Antidepressants, Antipsychotics, Antiepileptics (AEDs), Dopaminergic Agents, Neuroprotective Agents, Immunomodulators, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Japan Central Nervous System Therapeutic Market Insights, Industry Trend, Forecasts to 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
128
Pages:
187
Countries covered:
1
Companies covered::
12
Forecast CAGR:
9.4%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies